Mckesson Medical-Surgical Inc. Corporate Office recalls PROLIA (denosumab)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations; potential temperature excursions due to transit delays
- Products
-
- PROLIA (denosumab)
- Where it was sold
-
Within the U.S - OH, VA, FL.
States: Florida, Ohio, Virginia
- Units affected
- 6 Pre-filled syringes
- About this recall
- PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-710-21